HIBCH and colorectal carcinoma: Indeed, the present study demonstrated that treatment with bevacizumab elevated both protein and mRNA levels of HIBCH in CRC cells in time- and dose-dependent manners (Fig. 7a, b), which may be back to bite the effect of the drug.